Skip to main content
Premium Trial:

Request an Annual Quote

BioDot, Scienion to Co-develop Liquid-Handling Tools; Scienion to Enter US Market

NEW YORK, Sept. 13 (GenomeWeb News) - BioDot and picoliter liquid handling company Scienion plan to co-develop low-volume liquid-handling products, the companies said today.

 

The alliance also calls for BioDot to distribute Scienion products in North America, which represents Scienion's first step into the US market.

 

To develop the new tools, BioDot will marry its BioJet Plus technology and Scienion's sciFlexarrayer products, the companies said.


Financial terms of the alliance were not disclosed.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.